This article provides a comprehensive guide for researchers and drug development professionals on mitigating false positive results in quantitative PCR (qPCR) assays for cancer detection and monitoring.
This article provides a comprehensive guide for researchers and drug development professionals facing the challenge of high cycle threshold (Ct) values in the detection of low-abundance cancer biomarkers.
Obtaining reliable quantitative PCR (qPCR) results from low-quality or inhibitor-rich RNA samples is a common challenge in biomedical research and drug development.
This article provides a comprehensive guide for researchers and drug development professionals on implementing quantitative PCR (qPCR) for minimal residual disease (MRD) detection.
Copy number alterations (CNAs) are critical drivers of oral squamous cell carcinoma (OSCC), influencing oncogene activation, tumor suppressor silencing, and patient prognosis.
This article provides a comprehensive guide for researchers and drug development professionals on the application of Reverse Transcription Quantitative Polymerase Chain Reaction (RT-qPCR) for analyzing angiogenesis biomarkers in tumor tissue.
Circulating microRNAs in plasma have emerged as promising minimally invasive biomarkers for various diseases, from cancer to ageing-related disorders.
This article provides a comprehensive guide for researchers and drug development professionals on implementing TaqMan assay protocols for somatic mutation detection in cancer research.
This article provides a comprehensive guide for researchers and drug development professionals on selecting between one-step and two-step RT-qPCR protocols for cancer biomarker applications.
This comprehensive guide explores the foundational principles, methodologies, and best practices for real-time PCR data analysis in gene expression profiling.